<DOC>
	<DOCNO>NCT01403311</DOCNO>
	<brief_summary>This study aim determine safety utility use 5-Aminolevulinic Acid ( ALA ) remove malignant brain tumor surgery .</brief_summary>
	<brief_title>A Study Aminolevulinic Acid ( ALA ) Enhance Visualization Resection Malignant Glial Tumors Brain</brief_title>
	<detailed_description>This study aim determine safety utility use 5-Aminolevulinic Acid ( ALA ) remove brain tumor surgery . When ALA provide increased concentration , protoporphorin concentration malignant cell increase render cell fluorescent long ultraviolet light . This study look use oral ALA help identify tumor cell intraoperatively facilitate complete resection . Oral ALA give prior image-guided microsurgical resection tumor . Following tumor resection light microscopy , tumor bed illuminated residual fluorescent tissue cavity surgically remove leading complete resection tumor . Pathologic confirmation tumor type make neuropathology . Photosensitizer concentration malignant normal tissue estimate fluorescence microscopy .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Patients must clinically document primary brain tumor resection clinically indicate . The anticipated histology resection include : Anaplastic astrocytoma , Astrocytoma , Brain stem glioma , Ependymoma , Glioblastoma , Glioblastoma multiforme , Gliosarcoma , oligodendroglioma , Medulloblastoma , Mixed astrocytomaependymoma Patients may prior therapy 18 year age Male Female Life expectancy consideration protocol entry Patients must normal organ marrow function define : Leukocytes &gt; 3,000/mL , Absolute neutrophil count &gt; 1,500/mL , Platelets &gt; 100,000/mL , Total bilirubin within normal institutional limit AST ( SGOT ) /ALT ( SGPT ) &lt; 2.5 X institutional upper limit normal , Creatinine within normal institutional limit Creatinine clearance &gt; 60 mL/min/1.73 m2 patient creatinine level institutional normal Confirmation Glial Tumor Gross total resection aim surgery Ability understand willingness sign write informed consent document parent guardian ability understand willingness sign write informed consent . NonGlial tumor i.e . tumor abscess , metastasis , lymphoma , vasculitis Tumor perforate vessel Tumor involve critical fiber track Use microsurgical tool monopolar loop Subject preexist severe deficit concern language motor function resolve steroid Performance Status le 60 Prior therapy exclusion criterion Patients may receive investigational agent History allergic reaction attribute compound similar chemical biologic composition aminolevulinic acid ( ALA ) Personal family history porphorias Uncontrolled intercurrent illness include , limited ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Anaplastic astrocytoma</keyword>
	<keyword>Astrocytoma</keyword>
	<keyword>Brain stem glioma</keyword>
	<keyword>Ependymoma</keyword>
	<keyword>Glioblastoma</keyword>
	<keyword>Glioblastoma multiforme</keyword>
	<keyword>Gliosarcoma</keyword>
	<keyword>oligodendroglioma</keyword>
	<keyword>Medulloblastoma</keyword>
	<keyword>Mixed astrocytoma-ependymoma</keyword>
	<keyword>ALA</keyword>
</DOC>